Jefferies & Co initiates coverage on ev3 Inc. (EVVV) with a Buy
More News related to EVVV
- Matrix USA Rating Changes 8/26
- ev3 Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
- JANA Partners 13F Shows New Stakes in Genentech (DNA), Sears (SHLD), Washington Mutual (WM); Adds to Positions in AK Steel (AKS), Focus Media (FMCN), Transocean (RIG); Sells Out of Apple (AAPL), Lehma
- ev3 (EVVV) Director Buys 50K Shares
- ev3 Inc. Appoints Douglas W. Kohrs to Board of Directors
Jefferies & Co initiates coverage on ev3 Inc. (Nasdaq: EVVV) with a Buy, citing positive growth outlook and business opportunities. Price target $15
ev3 Inc. (ev3) is a global medical device company focused on catheter-based technologies for the endovascular treatment of vascular diseases and disorders.
Related Categories
New CoverageStocks Mentioned
-0.22Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
